bioRxivNeurosciencePreprint
Regulation of neuronal mRNA splicing and Tau isoform ratio by ATXN3 through deubiquitylation of splicing factors
Andreia Neves‐CarvalhoiD, Sara Duarte‐SilvaiD, Joana Margarida SilvaiD, Liliana Meireles-Costa, Daniela Monteiro‐FernandesiD, Joana Sofia CorreiaiD, Beatriz RodriguesiD, Sasja Heetveld, Bruno AlmeidaiD, Natalia SavytskaiD, Jorge Diogo Da SilvaiD, Andreia Teixeira‐CastroiD, Ioannis SotiropoulosiD, Ana Luı́sa CarvalhoiD, Peter HeutinkiD, Ka Wan LiiD, Patrı́cia MacieliD
Abstract
The ubiquitylation/deubiquitylation balance in cells is maintained by deubiquitylating enzymes, including ATXN3. The precise role of this protein, mutated in spinocerebellar ataxia type 3 (SCA3), remains elusive, as few substrates for its deubiquitylating activity were identified. Here, we characterized the ubiquitome of neuronal cells lacking ATXN3, and found altered polyubiquitylation in a large proportion of proteins involved in RNA metabolism, including splicing factors. Using transcriptomic analysis and reporter minigenes we confirmed that splicing was globally altered in these cells. Among the candidate targets of ATXN3 was SRSF7 (9G8), a key regulator of MAPT (Tau) exon 10 splicing. Loss-of-function of ATXN3 led to reduced SRSF7 levels and a deregulation of MAPT exon 10 splicing, resulting in a decreased 4R/3R-Tau ratio. Similar alterations were found in cellular models of expanded polyQ ATXN3 and SCA3 patient brains, pointing to a relevant role of this mechanism in SCA3, and establishing a previously unsuspected link between two key proteins involved in different neurodegenerative disorders.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Regional and age-dependent changes in ubiquitination in cellular and mouse models of Spinocerebellar ataxia type 3
Haiyang Luo, Sokol V. Todi, … Maria do Carmo Costa·Frontiers in Molecular NeurosciencePeer-reviewed·Apr 14, 2023
- Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph disease
Mafalda Raposo, Jeannette Hübener‐Schmid, … Manuela Caroline Ferreira Lima·bioRxiv·Apr 22, 2023
- Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia Type 3 disease protein
Naila S. Ashraf, Joanna R. Sutton, … Maria do Carmo Costa·Neurobiology of DiseasePeer-reviewed·Nov 26, 2019
- Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3
Jessica R. Blount, Nikhil C. Patel, … Sokol V. Todi·bioRxiv·May 30, 2023
- Autophagosome-tethering compounds selectively lower mutant ataxin-3 in preclinical models of spinocerebellar ataxia type 3
Hongyu Yuan, Zhao Chen, … Hong Jiang·bioRxiv·Oct 8, 2026
- Impaired oligodendrocyte maturation is an early feature in SCA3 disease pathogenesis
Kristen H. Schuster, Annie J. Zalon, … Hayley S. McLoughlin·Journal of NeurosciencePeer-reviewed·Jan 18, 2022